We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MTS:ASXMetcash Limited Analysis

Data as of 2026-06-12 - not real-time

A$3.21

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Metcash shares are trading at AUD 3.21, comfortably above the 20‑day SMA (3.04) but below the 200‑day SMA (3.38), indicating a neutral price trend. The RSI of 65.7 suggests momentum is still positive without being overbought, while the MACD histogram is bullish and the signal line is supportive. Volume is on an increasing trend, giving the recent price action credibility, and the stock sits near its technical resistance at AUD 3.22 with support around AUD 2.90. Volatility is elevated at roughly 33% over the past 30 days, yet the beta of 0.28 signals low systematic risk, and the Fear‑Greed Index reads “Extreme Greed” at 87.7, reflecting strong market appetite.
Fundamentally, the company delivers a high dividend yield of 5.61% with a payout ratio under 70%, supported by positive operating and free cash flow. A DCF‑derived fair value of AUD 3.74 provides an upside potential of about 10%, classifying the stock as undervalued. The defensive consumer sector, modest revenue growth, and solid ROE of 17.5% underpin a value‑oriented case, while a debt‑to‑equity of 112% calls for monitoring. Overall, the combination of attractive yield, technical strength, and valuation upside makes MTS a compelling buy for income‑focused investors.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and strong momentum (RSI 65)
  • Increasing volume supporting price stability
  • Attractive dividend yield above 5%

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicating ~10% upside
  • Undervalued relative to price
  • Sustainable cash flow to fund dividends

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Defensive consumer sector provides stability
  • Limited revenue growth and high leverage
  • High dividend yield offers income but caps capital appreciation

Key Metrics & Analysis

Financial Health

Revenue Growth0.10%
Profit Margin1.64%
P/E Ratio12.3
ROE17.50%
ROA3.98%
Debt/Equity112.43
P/B Ratio2.1
Op. Cash FlowA$637.3M
Free Cash FlowA$450.6M

Technical Analysis

TrendNeutral
RSI65.7
SupportA$2.90
ResistanceA$3.22
MA 20A$3.04
MA 50A$2.95
MA 200A$3.38
MACDBullish
VolumeIncreasing
Fear & Greed Index87.7

Valuation

Fair ValueA$3.74
Target PriceA$3.54
Upside/Downside10.40%
GradeUndervalued
TypeValue
Dividend Yield5.61%

Risk Assessment

Beta0.28
Volatility33.08%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.